Metraipolis › archive › dc_2bf4768a87e6

Concurrent Use of Anifrolumab and Belimumab in a Patient With Systemic Lupus Erythematosus Presenting With Recurrent Severe Cutaneous Involvement and Lupus… — Europe PMC PMID:41426928

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41426928
DOI
10.7759/cureus.97252
License (as archived)
solo-consultazione
Archived
2026-11-08T10:57:53.376Z
SHA-256 of the archived text
74ecac39ab72cb500f2c5cb34e27eae9f686858d3a3998271af9c82ef04a952b
Stable URL of this page
https://metraipolis.com/documento/dc_2bf4768a87e6

How to cite

Concurrent Use of Anifrolumab and Belimumab in a Patient With Systemic Lupus Erythematosus Presenting With Recurrent Severe Cutaneous Involvement and Lupus… — Europe PMC PMID:41426928 — Europe PMC (en), https://europepmc.org/article/MED/41426928 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bf4768a87e6 (Metraipolis archive dc_2bf4768a87e6, sha256 74ecac39ab72cb500f2c5cb34e27eae9f686858d3a3998271af9c82ef04a952b)
BibTeX
@misc{dc2bf4768a87e6,
  title = {Concurrent Use of Anifrolumab and Belimumab in a Patient With Systemic Lupus Erythematosus Presenting With Recurrent Severe Cutaneous Involvement and Lupus… — Europe PMC PMID:41426928},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41426928},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bf4768a87e6; sha256 74ecac39ab72cb500f2c5cb34e27eae9f686858d3a3998271af9c82ef04a952b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41426928. Agents can read the archived copy with the MCP tool read_document.